Kathrin Hohl

988 total citations
30 papers, 763 citations indexed

About

Kathrin Hohl is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kathrin Hohl has authored 30 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Kathrin Hohl's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Kathrin Hohl is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Kathrin Hohl collaborates with scholars based in Germany, United States and Japan. Kathrin Hohl's co-authors include Sven N. Reske, Gerhard Glatting, Peter Kletting, Christina Ring, Felix M. Mottaghy, Richard E. Hautmann, L. Rinnab, Norbert M. Blumstein, Peter Stopfer and Fabian Müller and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Urology and European Respiratory Journal.

In The Last Decade

Kathrin Hohl

28 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin Hohl Germany	15	280	257	194	107	97	30	763
Michael Tapner Australia	13	141 0.5×	258 1.0×	223 1.1×	35 0.3×	187 1.9×	27	965
Jawaid Younus Canada	17	263 0.9×	60 0.2×	276 1.4×	16 0.1×	58 0.6×	54	823
Carl A. Wesolowski Canada	10	273 1.0×	272 1.1×	237 1.2×	216 2.0×	9 0.1×	30	767
M. Treskes Netherlands	15	195 0.7×	144 0.6×	203 1.0×	33 0.3×	16 0.2×	26	988
Amit B. Shah United States	12	556 2.0×	109 0.4×	122 0.6×	79 0.7×	11 0.1×	33	1.0k
B Nosslin Sweden	19	143 0.5×	132 0.5×	122 0.6×	164 1.5×	35 0.4×	52	1.0k
Koichiro Abe Japan	23	441 1.6×	760 3.0×	198 1.0×	22 0.2×	24 0.2×	92	1.7k
Hette Faber Netherlands	19	562 2.0×	661 2.6×	296 1.5×	72 0.7×	108 1.1×	32	1.9k
Jiong Zhang China	17	112 0.4×	47 0.2×	226 1.2×	142 1.3×	320 3.3×	52	1.2k
Takashi Naruke Japan	17	997 3.6×	488 1.9×	200 1.0×	15 0.1×	44 0.5×	62	1.7k

Countries citing papers authored by Kathrin Hohl

Since Specialization

Citations

This map shows the geographic impact of Kathrin Hohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Hohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Hohl more than expected).

Fields of papers citing papers by Kathrin Hohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Hohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Hohl. The network helps show where Kathrin Hohl may publish in the future.

Co-authorship network of co-authors of Kathrin Hohl

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Hohl. A scholar is included among the top collaborators of Kathrin Hohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Hohl. Kathrin Hohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Yang, et al.. (2025). Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Nerandomilast (BI 1015550) in Participants With and Without Hepatic Impairment. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1765–A1765.

Schulze, Friedrich, et al.. (2025). Phase 1 studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 690517 (vicadrostat), a novel aldosterone synthase inhibitor, in healthy male volunteers. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 9083–9098. 3 indexed citations

Moschetti, Viktoria, et al.. (2024). Relative bioavailability, immunogenicity, and safety of two adalimumab-adbm formulations in healthy volunteers: a double-blind, randomized, single-dose, parallel-arm Phase I trial (VOLTAIRE-HCLF). Expert Opinion on Biological Therapy. 24(7). 673–679.

Müller, Fabian, Kathrin Hohl, Sascha Keller, et al.. (2023). N¹‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid. Clinical Pharmacology & Therapeutics. 113(5). 1070–1079. 15 indexed citations

Vogel‐Claussen, Jens, Philipp Badorrek, Meike Müller, et al.. (2023). The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers. Pulmonary Pharmacology & Therapeutics. 82. 102246–102246. 1 indexed citations

Wiebe, Sabrina, Thomas Gießmann, Kathrin Hohl, et al.. (2020). Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. Clinical Pharmacokinetics. 59(12). 1627–1639. 45 indexed citations

Stopfer, Peter, Thomas Gießmann, Kathrin Hohl, et al.. (2018). Optimization of a drug transporter probe cocktail: potential screening tool for transporter‐mediated drug–drug interactions. British Journal of Clinical Pharmacology. 84(9). 1941–1949. 40 indexed citations

Richeldi, Luca, Sophie Fletcher, Huzaifa Adamali, et al.. (2018). No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone. European Respiratory Journal. 53(1). 1801060–1801060. 20 indexed citations

Stopfer, Peter, Thomas Gießmann, Kathrin Hohl, et al.. (2017). Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail. European Journal of Drug Metabolism and Pharmacokinetics. 43(1). 69–80. 27 indexed citations

10.

Cui, Yimin, et al.. (2015). Relative bioavailability study of linagliptin/ metformin tablets in healthy Chinese subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(7). 582–593. 2 indexed citations

11.

Ring, Arne, Tom Morris, Kathrin Hohl, & Robert Schall. (2014). Indirect bioequivalence assessment using network meta-analyses. European Journal of Clinical Pharmacology. 70(8). 947–955. 3 indexed citations

12.

Macha, Sreeraj, et al.. (2013). Effect of food on the pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and assessment of dose proportionality in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 51(11). 873–879. 20 indexed citations

13.

Kramer, Michael D., Kathrin Hohl, Ulrich Bockholt, Florian Schneider, & Christoph Dehner. (2013). Training effects of combined resistance and proprioceptive neck muscle exercising. Journal of Back and Musculoskeletal Rehabilitation. 26(2). 189–197. 9 indexed citations

14.

Netzer, Nikolaus C., et al.. (2010). The need for pressure changes in CPAP therapy 2–3 months after initial treatment. Sleep And Breathing. 15(1). 107–112. 14 indexed citations

15.

Rinnab, L., Richard E. Hautmann, Marcus V. Cronauer, et al.. (2009). [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World Journal of Urology. 27(5). 619–625. 71 indexed citations

16.

Klass, Oliver, Kathrin Hohl, Sebastian Feuerlein, et al.. (2009). Multidetector Computed Tomography Coronary Angiography. Journal of Computer Assisted Tomography. 33(2). 199–203. 14 indexed citations

17.

Kramer, Michael D., et al.. (2008). Reliability of a new virtual reality test to measure cervicocephalic kinaesthesia. Journal of Electromyography and Kinesiology. 19(5). e353–e361. 12 indexed citations

18.

Rinnab, L., Felix M. Mottaghy, Norbert M. Blumstein, et al.. (2007). Evaluation of [ ¹¹ C]‐choline positron‐emission/computed tomography in patients with increasing prostate‐specific antigen levels after primary treatment for prostate cancer. British Journal of Urology. 100(4). 786–793. 104 indexed citations

19.

Rinnab, L., Norbert M. Blumstein, Felix M. Mottaghy, et al.. (2007). ¹¹ C‐Choline positron‐emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer. British Journal of Urology. 99(6). 1421–1426. 39 indexed citations

20.

Glatting, Gerhard, Marguerite Müller, Kathrin Hohl, et al.. (2006). Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.. PubMed. 47(8). 1335–41. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact